{
    "2019-05-20": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock",
                "features": {
                    "keywords": [
                        "Credit Suisse",
                        "Pfizer",
                        "Double Down"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Dividend",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Interesting LLY Put And Call Options For August 16th",
                "features": {
                    "keywords": [
                        "LLY",
                        "Put",
                        "Call",
                        "Options"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}